Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study.

Antiplatelet and anticoagulant therapy after intracerebral hemorrhage.

Y-grafts and sequential grafts in coronary bypass surgery: a critical evaluation of patency rates.

Factors influencing patency of femoropopliteal artery bypass grafts.

Anticoagulant and antiplatelet therapy during ocular surgery.

Aortocoronary saphenous vein bypass grafts. Long-term patency, morphology and blood flow in patients with patent grafts early after surgery.

Response to letter regarding article, "optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial".

Preoperative continuation of aspirin therapy may improve perioperative saphenous venous graft patency after off-pump coronary artery bypass grafting.

Can therapy dogs improve pain and satisfaction after total joint arthroplasty? A randomized controlled trial.

Effect of aorto-coronary grafts and native vessel patency on the occurrence of angina pectoris after coronary bypass surgery.

Effect of dipyridamole (Persantin) on blood flow and patency of aortocoronary vein bypass grafts.

Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study.

Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a meta-analysis of 3 randomized controlled trials.

Angiographic demonstration of no-flow anatomical patency of internal thoracic-coronary artery bypass grafts.

A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons.

Antiplatelet, anticoagulant, and profibrinolytic activities of baicalin.

Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study.

on-pump play a role?

Thrombolytic-plus-Anticoagulant Therapy versus Anticoagulant-Alone Therapy in Submassive Pulmonary Thromboembolism (TVASPE Study): A Randomized Clinical Trial.

Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials.

Saphenous vein bypass grafts: Long-term patency and effect on the native coronary circulation.

Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in the Setting of Acute Coronary Syndrome.

Optimizing autologous cell grafts to improve stem cell gene therapy.

SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation.

Antiplatelet, anticoagulant, and profibrinolytic activities of cudratricusxanthone A.

Suggest Documents

Antiplatelet and anticoagulant therapy after intracerebral hemorrhage.

Y-grafts and sequential grafts in coronary bypass surgery: a critical evaluation of patency rates.

Factors influencing patency of femoropopliteal artery bypass grafts.

Anticoagulant and antiplatelet therapy during ocular surgery.

Aortocoronary saphenous vein bypass grafts. Long-term patency, morphology and blood flow in patients with patent grafts early after surgery.

Response to letter regarding article, "optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial".

Preoperative continuation of aspirin therapy may improve perioperative saphenous venous graft patency after off-pump coronary artery bypass grafting.

Can therapy dogs improve pain and satisfaction after total joint arthroplasty? A randomized controlled trial.

Effect of aorto-coronary grafts and native vessel patency on the occurrence of angina pectoris after coronary bypass surgery.

Effect of dipyridamole (Persantin) on blood flow and patency of aortocoronary vein bypass grafts.

Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study.

Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a meta-analysis of 3 randomized controlled trials.

Angiographic demonstration of no-flow anatomical patency of internal thoracic-coronary artery bypass grafts.

A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons.

Antiplatelet, anticoagulant, and profibrinolytic activities of baicalin.

Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study.

on-pump play a role?

Thrombolytic-plus-Anticoagulant Therapy versus Anticoagulant-Alone Therapy in Submassive Pulmonary Thromboembolism (TVASPE Study): A Randomized Clinical Trial.

Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials.

Saphenous vein bypass grafts: Long-term patency and effect on the native coronary circulation.

Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in the Setting of Acute Coronary Syndrome.

Optimizing autologous cell grafts to improve stem cell gene therapy.

SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation.

Antiplatelet, anticoagulant, and profibrinolytic activities of cudratricusxanthone A.

Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study.

Recommend Documents

Follow Us